Cargando…
UPR(mt) activation improves pathological alterations in cellular models of mitochondrial diseases
BACKGROUND: Mitochondrial diseases represent one of the most common groups of genetic diseases. With a prevalence greater than 1 in 5000 adults, such diseases still lack effective treatment. Current therapies are purely palliative and, in most cases, insufficient. Novel approaches to compensate and,...
Autores principales: | Suárez-Rivero, Juan M., Pastor-Maldonado, Carmen J., Povea-Cabello, Suleva, Álvarez-Córdoba, Mónica, Villalón-García, Irene, Talaverón-Rey, Marta, Suárez-Carrillo, Alejandra, Munuera-Cabeza, Manuel, Reche-López, Diana, Cilleros-Holgado, Paula, Piñero-Perez, Rocío, Sánchez-Alcázar, José A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115953/ https://www.ncbi.nlm.nih.gov/pubmed/35581596 http://dx.doi.org/10.1186/s13023-022-02331-8 |
Ejemplares similares
-
mtUPR Modulation as a Therapeutic Target for Primary and Secondary Mitochondrial Diseases
por: Cilleros-Holgado, Paula, et al.
Publicado: (2023) -
Therapeutic approach with commercial supplements for pantothenate kinase-associated neurodegeneration with residual PANK2 expression levels
por: Álvarez-Córdoba, Mónica, et al.
Publicado: (2022) -
Pantothenate and L-Carnitine Supplementation Improves Pathological Alterations in Cellular Models of KAT6A Syndrome
por: Munuera-Cabeza, Manuel, et al.
Publicado: (2022) -
Vicious cycle of lipid peroxidation and iron accumulation in neurodegeneration
por: Villalón-García, Irene, et al.
Publicado: (2022) -
Activation of the Mitochondrial Unfolded Protein Response: A New Therapeutic Target?
por: Suárez-Rivero, Juan M., et al.
Publicado: (2022)